Wen Wen
Impact in
- Infectious Diseases top 2%
- COVID-19 Clinical Research Studies
- SARS-CoV-2 and COVID-19 Research
- Immunology top 5%
- Immunotherapy and Immune Responses
- Immune Cell Function and Interaction
Papers in
- Epidemiology 10
- Influenza Virus Research Studies 3
-
- SARS-CoV-2 and COVID-19 Research 6
- COVID-19 Clinical Research Studies 4
- Co-authors
- Wenru Su (3 shared papers)Hao Tang (3 shared papers)Yingfeng Zheng (3 shared papers)Lihui Xie (2 shared papers)Xiuxing Liu (2 shared papers)Yushan Miao (2 shared papers)Chuan‐Le Xiao (2 shared papers)Hongyang Wang (2 shared papers)
- Journals
- Journal of Infection (5 papers)Frontiers in Immunology (2 papers)Cell Discovery (2 papers)Clinical Cancer Research (1 paper)Journal of Cellular Biochemistry (1 paper)
- Partner nations
- ChinaJapanUnited States
In The Last Decade
Wen Wen
39 papers receiving 1.6k citations
Hit Papers
Peers
Comparison fields: 5 of 120
- Infectious Diseases 727
- Immunology 439
- Neurology 295
- Hepatology 94
- Oncology 291
Countries citing papers authored by Wen Wen
This map shows the geographic impact of Wen Wen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wen Wen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wen Wen more than expected).
Fields of papers citing papers by Wen Wen
This network shows the impact of papers produced by Wen Wen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wen Wen. The network helps show where Wen Wen may publish in the future.
Co-authors
The 25 scholars most cited alongside Wen Wen, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 40 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Immune cell profiling of COVID-19 patients in the recovery stageby single-cell sequencing Hit paper breakdown → | 2020 | 524 |
| 2 | Efficacy and safety of three new oral antiviral treatment (molnupiravir, fluvoxamine and Paxlovid) for COVID-19：a meta-analysis Hit paper breakdown → | 2022 | 272 |
| 3 | 2016 | 244 | |
| 4 | 2020 | 112 | |
| 5 | 2017 | 104 | |
| 6 | 2020 | 69 | |
| 7 | 2015 | 52 | |
| 8 | 2013 | 36 | |
| 9 | 2019 | 27 | |
| 10 | 2015 | 26 | |
| 11 | 2021 | 22 | |
| 12 | 2013 | 22 | |
| 13 | 2022 | 20 | |
| 14 | 2019 | 13 | |
| 15 | 2021 | 11 | |
| 16 | 2021 | 10 | |
| 17 | 2022 | 10 | |
| 18 | 2022 | 9 | |
| 19 | 2017 | 8 | |
| 20 | 2013 | 6 |
About Wen Wen
Wen Wen is a scholar working on Epidemiology, Infectious Diseases, Immunology, Neurology and Aquatic Science, having authored 40 papers that have together received 1.6k indexed citations. Recurring topics across this work include SARS-CoV-2 and COVID-19 Research (6 papers), Long-Term Effects of COVID-19 (5 papers), Aquaculture Nutrition and Growth (4 papers), COVID-19 Clinical Research Studies (4 papers), Reproductive biology and impacts on aquatic species (3 papers), Influenza Virus Research Studies (3 papers), Trauma and Emergency Care Studies (2 papers) and Intensive Care Unit Cognitive Disorders (2 papers). The work is most often cited by research in Infectious Diseases (727 citations), Immunology (439 citations), Neurology (295 citations), Hepatology (94 citations) and Oncology (291 citations). Wen Wen has collaborated with scholars based in China, Japan and United States. Frequent co-authors include Wenru Su, Hao Tang, Yingfeng Zheng, Lihui Xie, Xiuxing Liu, Yushan Miao, Chuan‐Le Xiao, Hongyang Wang, Xiuliang Cui and Depeng Wang. Their work appears in journals such as Journal of Infection, Frontiers in Immunology, Cell Discovery, Clinical Cancer Research and Journal of Cellular Biochemistry.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.